Atlas Antibodies logo

Atlas Antibodies

Empowering Protein Discovery | Antibodies Validated by the Human Protein Atlas

69 employees · est. 2006 · Stockholm, Sweden

VS
Seer logo

Seer

Empowering scientists through unbiased, deep, rapid proteomics at scale

151 employees · est. 2017 · Redwood City, United States

Atlas Antibodies is the older company (2006 vs 2017).

Side-by-Side Comparison

Atlas Antibodies Seer
Founded
2006 older 2017
Headquarters
Stockholm, Sweden Redwood City, United States
Employees
69 151
Industry
Biotechnology Biotechnology
Funding Stage
Seed IPO
Total Funding
Not tracked yet $344.50M
Funding Rounds
2 7
Services
AtlasPlex Custom Multiplex IHC Kit, MolBoolean Assays, Triple A Polyclonal Antibodies, PrecisA Monoclonal Antibodies, PrEST Control Antigens Proteograph Product Suite, Seer Technology Access Center, Proteomics Research Projects, Seer Service Provider Solutions, AI-Driven Multi-Cancer Screening
Target Customers
Researchers, Clinicians, Biotechnology Companies, Academic Institutions, Pharmaceutical Companies Research Scientists, Biotechnology Companies, Academic Institutions, Healthcare Providers, Pharmaceutical Companies
Taxonomy
Proteomics, Antibody Validation, Primary Antibodies, Monoclonal Antibodies, Polyclonal Antibodies, Spatial Biology, Immunohistochemistry (IHC), Western Blot (WB), Immunofluorescence (IF), Cancer Research, Neuroscience, Protein Quantification, Drug Discovery, Protein-Protein Interactions, Multiplex Proteomics Proteomics, Deep Proteomics, Unbiased Proteomics, Large-scale Studies, Proteomic Mass Spectrometry, Biomarker Discovery, Scientific Tools, Life Sciences, Multiomics, Diagnostics Solutions, Genomics-proteomics Integration, Technology Innovation, Biological Insights, Health And Disease Biology, Protein Diversity Analysis
Website
atlasantibodies.com seer.bio
Atlas Antibodies logo

About Atlas Antibodies

Atlas Antibodies, born from the prestigious Human Protein Atlas project, is empowering the global scientific community to accelerate discovery with high-standard antibodies. Founded in 2006, this Biotechnology startup is a leader in developing, manufacturing, and supplying primary antibodies, antige...

Seer logo

About Seer

Seer, founded in 2017, is at the forefront of the Biotechnology industry, with a mission encapsulated by its slogan: "Empowering scientists through unbiased, deep, rapid proteomics at scale." This innovative company is pioneering solutions to bridge the gap in proteomics technology that has historic...

We will tell you when either one moves

BounceWatch watches Atlas Antibodies and Seer for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Atlas Antibodies and Seer — by email.

Frequently Asked Questions

Atlas Antibodies — Empowering Protein Discovery | Antibodies Validated by the Human Protein Atlas. Seer — Empowering scientists through unbiased, deep, rapid proteomics at scale. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Atlas Antibodies has raised undisclosed funding while Seer has raised $344.50M.
Atlas Antibodies and Seer operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Atlas Antibodies with someone else

Start typing a company name or domain.

Related Comparisons

Compiled from the BounceWatch company index. We last looked at Atlas Antibodies on 15 Jun 2026, and Seer on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy